§ Same category · GLP-1 / metabolic peptides
Mazdutide vs Orforglipron
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Mazdutide
0
vendors tracked
Orforglipron
0
vendors tracked
Mazdutide
GLP-1/glucagon dual agonist
No current listings at 10mg.
Orforglipron
Oral small-molecule GLP-1 agonist
No current listings at 0.024mg.
About Mazdutide
A dual GLP-1 and glucagon receptor agonist in late-stage clinical development for obesity, type-2 diabetes, and metabolic-associated fatty liver disease.
About Orforglipron
An oral non-peptide GLP-1 receptor agonist in Phase 3 for obesity and type-2 diabetes. Typically sold as capsules in research-compound form.